Results 131 to 140 of about 6,056 (173)

Navigating hepatotoxicity of antibody-drug conjugates: from mechanistic insights to clinical and postmarketing evidence. [PDF]

Front Pharmacol
Dong Y, Zhi Y, Li X, Ma M, Ye M, Huang S, Tang J, Zhong W, Lei X, Mao Y.   +9 more
europepmc   +1 more source

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real-World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data. [PDF]

Pharmacotherapy
Rahurkar S, Ouyang J, Jonnalagadda P, Liu X, Zhang S, Chiang CW, Wang L, Shendre A, Li L.   +8 more
europepmc   +1 more source

Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy. [PDF]

Am J Addict
Ramage M, Bishop B, Mangano V, Mankabady B.   +3 more
europepmc   +1 more source

Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan. [PDF]

ESMO Open
Kawakami H, Uchino K, Hashimoto W, Muro K.   +3 more
europepmc   +1 more source

Real-world safety and effectiveness of alemtuzumab for relapsed or refractory chronic lymphocytic leukaemia: results from postmarketing surveillance in Japan. [PDF]

Jpn J Clin Oncol
Sasakura Y, Hatanaka M, Ishizawa K.
europepmc   +1 more source

Editorial: hepatitis C direct acting antiviral agents and the kidney—authors’ reply [PDF]

, 2017
Duarte-Rojo, A. (Andres), Feld, J.J. (Jordan J.), Maan, R. (Raoel)   +2 more
core   +4 more sources

Risk of severe infections in patients with triple-negative breast cancer treated with atezolizumab plus nab-paclitaxel: a real-world, postmarketing database study in Japan. [PDF]

Int J Clin Oncol
Yuri A, Nakane S, Miyano Y, Yamada K, Sugano H, Nakatsuji E, Aoki M, Murayama A.   +7 more
europepmc   +1 more source

Applied intelligence in clinical drug development: Potential benefits and emerging concerns. [PDF]

Perspect Clin Res
Bhatt A.
europepmc   +1 more source

Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study. [PDF]

J Dermatol
Ohtsuki M, Okubo Y, Saeki H, Igarashi A, Imafuku S, Abe M, Saito K, Ogawa R, Morita A.   +8 more
europepmc   +1 more source

Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report [PDF]

, 2017

core   +1 more source